Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review
Khadega A. Abuelgasim, Bandar Albuhayri, Rayan Munshi, Areej Al Mugairi, Bader Alahmari, Giamal Gmati, Hind Salama, Mohsen Alzahrani, Ayman Alhejazi, Ahmed Alaskar, Moussab Damlaj
Abstract
< 0.0001). Only those ≤40 had durable DFS and OS. HDC appears to improve the outcome of older AML patients.
Topics & Concepts
MedicineMyeloid leukemiaInternal medicineInduction chemotherapyChemotherapyOverall survivalOncologyRetrospective cohort studyInduction therapyLeukemiaMyeloidGastroenterologySurgeryAcute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and TreatmentNeutropenia and Cancer Infections